Institutional investors purchased a net $9.2 million shares of IMMU during the quarter ended December 2016, and now own 59.02% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EVERPOINT ASSET MANAGEMENT LLC Bought 3.3 Million shares of Immunomedics Inc
MILLENNIUM MANAGEMENT LLC Bought 1.6 Million shares of Immunomedics Inc
ARROWPOINT ASSET MANAGEMENT LLC Bought 1.5 Million shares of Immunomedics Inc